- Home
- SLS vs RPD Comparison
SLS vs RPD Comparison
Compare SLS & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLS | RPD |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 924.5M | 780.5M |
| IPO Year | 2007 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SLS | RPD |
|---|---|---|
| Price | $8.12 | $6.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 23 |
| Target Price | $10.00 | ★ $15.05 |
| AVG Volume (30 Days) | ★ 9.0M | 1.8M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $685,083,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $110.98 | $0.54 |
| P/E Ratio | ★ N/A | $340.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.39 | $4.97 |
| 52 Week High | $9.51 | $25.85 |
Technical Indicators
Market Signals| Indicator | SLS | RPD |
|---|---|---|
| Relative Strength Index (RSI) | 55.24 | 43.25 |
| Support Level | $7.07 | $5.97 |
| Resistance Level | $9.51 | $6.97 |
| Average True Range (ATR) | 0.66 | 0.47 |
| MACD | -0.16 | -0.15 |
| Stochastic Oscillator | 44.27 | 10.56 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About RPD Rapid7 Inc.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.